Celularity (CELUW) Gross Margin (2020 - 2025)

Celularity (CELUW) reported Gross Margin of 79.68% for Q4 2025, up 88762.0% year-over-year from N/an in Q4 2024, and down 405.09% quarter-over-quarter from 26.12% in Q3 2025.

Celularity (CELUW) Gross Margin (2020 - 2025) Analysis & Trends

Celularity (CELUW) has 6 years of Gross Margin data on file, last reported at 79.68% in Q4 2025.

  • Gross Margin for Q4 2025 came in at 79.68%, up 88762.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 24.39% (down 3485.0% YoY), and the FY2025 annual result was 24.39%, down 4796.0% from the prior year.
  • Gross Margin fell to 79.68% in Q4 2025 per CELUW's latest filing, from 26.12% in the prior quarter.
  • Over five years, Gross Margin peaked at 92.94% in Q3 2021 and troughed at 967.3% in Q4 2024.
  • A 5-year average of 2.7% and a median of 57.18% in 2022 frame the typical range for Gross Margin.
  • The sharpest annual moves came in 2024 and 2025: Gross Margin tumbled 98796 bps in 2024, then soared 88762 bps in 2025.
  • A 5-year view of Gross Margin shows it stood at 42.79% in 2021, then sank by 103 bps to 1.26% in 2022, then soared by 1741 bps to 20.67% in 2023, then slumped by 4781 bps to 967.3% in 2024, then soared by 92 bps to 79.68% in 2025.
  • Business Quant data shows CELUW's Gross Margin at 79.68% in Q4 2025, 26.12% in Q3 2025, and 8.61% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 79.04%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 86.85%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Celularity - - -3.27 Mn -79.68%

Historic Data

Download Data
DateValue
Dec 31, 2025 -79.68%
Sep 30, 2025 26.12%
Jun 30, 2025 8.61%
Mar 31, 2025 68.90%
Dec 31, 2024 -967.30%
Sep 30, 2024 58.23%
Jun 30, 2024 82.47%
Mar 31, 2024 88.83%
Dec 31, 2023 20.67%
Sep 30, 2023 4.86%
Jun 30, 2023 72.70%
Mar 31, 2023 49.10%
Dec 31, 2022 -1.26%
Sep 30, 2022 78.26%
Jun 30, 2022 88.74%
Mar 31, 2022 56.12%
Dec 31, 2021 42.79%
Sep 30, 2021 92.94%
Jun 30, 2021 82.14%
Mar 31, 2021 72.78%